KBC Group NV »

First Tracks Biotherapeutics shares owned by KBC Group NV

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by KBC Group NV from 13F filings

Historical chart of KBC Group NV investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by KBC Group NV consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by KBC Group NV

Quarter filed Position value Share count Share price at filing
2026-09-30 $41k 1.1k 35.68

More positions owned by KBC Group NV

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Applied Materials (AMAT)
JPMorgan Chase & Co. (JPM)
Intel Corporation (INTC)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson & Johnson (JNJ)

View all positions for KBC Group NV

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics